Kinase inhibitors - Globe Thesis

Keyword [Kinase inhibitors] Result: 161 - 180 \| Page: 9 of 10
161.	Synthesis Of Novel Indole Alcohol Derivatives As Tyrosine Kinase Inhibitors
162.	Synthesis And Activity Evaluation Of Novel Tyrosine Kinase Inhibitors And Synthesis Of New Anti-Radiation Molecules
163.	Studies On The Anti-tumor Effects And Its Molecular Mechanism Of 1H-Pyrazolo[3,4-d] Pyrimidine Derivatives As Pan-RAF Kinase Inhibitors
164.	Discovery And Pharmacological Studies Of Kinase Inhibitors For B-Cell Lymphoma
165.	The Research Of The Association Between BCR-ABL1 Fusion Gene Mutation And TKIs Resistance Based On Next-generation Sequencing
166.	Three-dimensional Quantitative Structure-activity Relationship Analyses And Molecular Docking Study For Activin Receptor-like Kinase Inhibitors
167.	Analysis Of Efficacy And Related Factors Of Acquired Deep Molecular Response In Chronic Myeloid Leukemia Patients Treated With TKI
168.	Clinical And Molecular Genetic Study On Chronic Myeloid Leukemia Thrated By Second Generation Tyrosine Kinase Inhibitors
169.	Study On The Relationship Between Polymorphisms Of The CYP3A5 Gene And Crizotinib-induced Hepatotoxicity
170.	Design, Synthesis And Anticancer Activity Of Pyrimidine Derivatives As Cyclin-dependent Kinase Inhibitors
171.	Role Of EMT In Radiosensitivity Of NSCLC With Acquired Resistance Of EGFR-TKI
172.	Study On Synthesis And Antitumor Activities Of New Type Of Small Molecules Pteridine
173.	Analysis Of The Efficacy After Discontinuation Of Tyrosine Kinase Inhibitors Treatment In Patients With Chronic Myelogenous Leukemia
174.	Outcomes Of Tyrosine Kinase Inhibitors Combined With Chemotherapy And Allogeneic Hematopoietic Stem Cell Transplantation In Philadelphia Chromosome-positive Adult Acute Lymphoblastic Leukemia
175.	Efficacy And Safety Of Stereotactic Body Radiation Therapy In The Management Of Oligopersistent Disease In Patients With Egfr Mutant Non-small Cell Lung Cancer During EGFR-TKIs Treatment
176.	Lead Discovery Of Rho Kinase Inhibitors: Design,biological Evaluation And Molecular Mechanism Study Of 4-aminopyridine Derivatives
177.	Synthesis And Biological Evaluation Of 2,4-disubstituted Phthalazinones As Aurora Kinase Inhibitors
178.	Sequential Treatment Of EGFR Tyrosine Kinase Inhibitors And Platinum Doublet Chemotherapy On Survival Of Advanced Non-small-cell Lung Cancer With EGFR Mutations
179.	AP Versus DP Chemotherapy Regimen As Second-line Therapy In EGFR-TKIs Treated Advanced Non-small-cell Lung Cancer Patients With EGFR Mutations
180.	Functional Research Of Resistance Mutations To EGFR Or MET Tyrosine Kinase Inhibitors In Lung Adenocarcinoma Patients
<<First <Prev Next> Last>> Jump to